ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 3.13X leverage
Performance
- Low
- ₹1,706
- High
- ₹1,739
- 52 Week Low
- ₹1,210
- 52 Week High
- ₹2,248
- Open Price₹1,722
- Previous Close₹1,738
- Volume11,337
- 50 DMA₹1,738.23
- 100 DMA₹1,756.63
- 200 DMA₹1,737.37
Investment Returns
- Over 1 Month + 5.14%
- Over 3 Month -8.09%
- Over 6 Month -13.14%
- Over 1 Year + 2.96%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 493.1
- PEG Ratio
- 4.2
- Market Cap Cr
- 19,702
- P/B Ratio
- 3.3
- Average True Range
- 58.04
- EPS
- 12.04
- Dividend Yield
- 0
- MACD Signal
- 22.81
- RSI
- 50.1
- MFI
- 44.89
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,719.40
-18.6
(-1.07%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹1,745.60
- 50 Day
- ₹1,738.23
- 100 Day
- ₹1,756.63
- 200 Day
- ₹1,737.37
Resistance and Support
1731.4
- R3 1,828.00
- R2 1,793.60
- R1 1,765.80
- S1 1,703.60
- S2 1,669.20
- S3 1,641.40
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,719 As on 13 January, 2026 | 11:34
The Market Cap of OneSource Specialty Pharma is ₹19701.8 Cr As on 13 January, 2026 | 11:34
The P/E ratio of OneSource Specialty Pharma is 493.1 As on 13 January, 2026 | 11:34
The PB ratio of OneSource Specialty Pharma is 3.3 As on 13 January, 2026 | 11:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.